Table 3.
Insulin resistance and Nrf2 | Regulation of Nrf2 | Suggested mechanism | Reference |
---|---|---|---|
Nrf2↑→insulin resistance↑ | Keap1-KD, Lep(ob/ob)-Keap1-KD mice |
Regulation of genes involved in glucose uptake and tolerance | [20] |
Nrf2↓→insulin resistance↓ | Nrf2-KO mice | FGF21 | [34] |
Nrf2↓→insulin resistance↓ | Nrf2-null mice, Keap1-KD mice |
Hepatic expression of insulin like growth factor binding protein-1 (Igfbp-1) and FGF21 | [35] |
Nrf2↓→insulin resistance↓ | Global Nrf2-KO mice Myeloid-selective Nrf2 deficiency mice |
Inflammatory gene expression | [41] |
Nrf2↓→insulin resistance↑ | STZ-treated Nrf2-null mice | Gluconeogenesis and Glycolysis-related genes |
[42] |
Nrf2↑→insulin resistance↑ | Chronic iAs exposure | Inflammatory gene and GLUT4 expression |
[44] |
Nrf2↑→insulin resistance↓ | Nrf2 agonist: oltipraz | AMPK signalling, p70S6 kinase, and GLUT4 expression | [27] |
Nrf2↑→insulin resistance↓ | Nrf2 agonist: ellagic acid | Attenuation of oxidative stress and inflammation in liver | [28] |
Nrf2↑→insulin resistance↓ | Nrf2 agonist: curcumin | Muscular mitochondrial redox balance | [30] |
Nrf2↑→insulin resistance↓ | Nrf2 agonist: curcumin | Adipose, hepatic, and systemic inflammation | [31] |
Nrf2↑→insulin resistance↓ | Nrf2 agonist: resveratrol | Hepatic oxidative stress | [33] |
Nrf2↑→insulin resistance↓ | Nrf2 agonist: resveratrol | Extracellular signal regulated kinase (ERK) pathway | [47] |
Nrf2↑→insulin resistance↓ | Nrf2 agonist (Dh404) | ERK pathway | [48] |